Clinical Trial Update: Zephyr Etude Post-Inscription (French Registry)

View source ↗

Summary

The Zephyr Etude Post-Inscription registry for emphysema or COPD, sponsored by Pulmonx, has COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Emphysema

Drugs mentioned

• Zephyr Endobronchial Valve (endobronchial valve)

Snippet

Sponsor: Pulmonx Corporation | Conditions: Emphysema or COPD | Status: COMPLETED